Higher-Risk
Showing 51 - 75 of >10,000
AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)
Recruiting
- AML, Adult
- APG 2575 ramp up arm
-
Baltimore, Maryland
- +6 more
Aug 12, 2022
Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease
Completed
- Sarcopenia
- +2 more
-
Shanghai, Shanghai, ChinaBaoshan Site of Shanghai Renji Hospital, Shanghai Jiaotong Unive
Jul 28, 2022
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Weaning Failure Trial in Toledo (Screening criteria for weaning and minimal ventilatory settings for spontaneous breathing
Recruiting
- Weaning Failure
- Screening criteria for weaning and minimal ventilatory settings for spontaneous breathing trial
-
Toledo, Castilla La Mancha, SpainHospital Virgen de la Salud
Aug 3, 2022
Colorectal Surgery, Surgical Wound Infection Trial in United States (gentamicin-collagen sponge dipped in saline)
Completed
- Colorectal Surgery
- Surgical Wound Infection
- gentamicin-collagen sponge dipped in saline
-
Florence, Alabama
- +38 more
Sep 22, 2021
Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +12 more
Jan 23, 2023
Syncope, Arrhythmia Trial in Vancouver, Ottawa (Cardiophone)
Active, not recruiting
- Syncope
- Arrhythmia
- Cardiophone
-
Vancouver, British Columbia, Canada
- +1 more
Oct 30, 2020
MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
-
Tucson, Arizona
- +36 more
Aug 1, 2022
MDS(MDS) Trial in China (Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA))
Not yet recruiting
- Myelodysplastic Syndromes(MDS)
- Lemzoparlimab+Azacitidine (AZA)
- Azacitidine (AZA)
-
Bengbu, An Hui, China
- +44 more
Jan 29, 2023
Brain Cancer, Brain Metastases, Melanoma Trial in Boston (radiation, drug, other)
Recruiting
- Brain Cancer
- +15 more
- Stereotactic Radiation
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 19, 2021
MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Denmark (Vitamin C, Placebo)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Vitamin C
- Placebo
-
Aalborg, Denmark
- +5 more
Sep 27, 2021
Pre-Eclampsia, Hypertension in Pregnancy, Obesity Trial in Houston (Aspirin 81 mg, Aspirin 162 mg)
Recruiting
- Pre-Eclampsia
- +2 more
- Aspirin 81 mg
- Aspirin 162 mg
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 10, 2021
Assessment in CKD and Kidney Transplanted Patients Following
Recruiting
- CKD
- +5 more
- FMD
- +6 more
-
Iasi, RomaniaDr CI Parhon Clinical Hospital of Iasi
Jan 5, 2022
Zonulin Biomarker for Diagnosis of Hip and Knee Infections
Enrolling by invitation
- Surgical Site Infection
- Zonulin
- Zonulin Biomarker
-
Philadelphia, PennsylvaniaRothman Orthopaedic Institute
Dec 8, 2020
MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Tamibarotene + Azacitidine
- Tamibarotene Matched Placebo + Azacitidine
-
Tucson, Arizona
- +87 more
Feb 2, 2023
Clinical Outcome in Acute Myeloid Leukemia and Related
Recruiting
- Acute Myeloid Leukemia (AML)
- Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)
-
Graz, Austria
- +83 more
Sep 28, 2021
MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)
Completed
- Myelodysplastic Syndromes
- +2 more
-
Birmingham, Alabama
- +58 more
Aug 24, 2022
Coronary Artery Disease Trial in Korea, Republic of (Prasugrel 5mg, Ticagrelor 60mg)
Unknown status
- Coronary Artery Disease
- Prasugrel 5mg
- Ticagrelor 60mg
-
Changwon, Gyeongsangnam-do, Korea, Republic of
- +7 more
Jan 28, 2021